D.A. Davidson & Co’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-4,928
| Closed | -$386K | – | 1089 |
|
|
2019
Q1 | $386K | Buy |
4,928
+2,259
| +85% | +$177K | 0.01% | 768 |
|
|
2018
Q4 | $226K | Sell |
2,669
-1,138
| -30% | -$96.4K | ﹤0.01% | 923 |
|
|
2018
Q3 | $652K | Sell |
3,807
-459
| -11% | -$78.6K | 0.01% | 624 |
|
|
2018
Q2 | $551K | Sell |
4,266
-1
| -0% | -$129 | 0.01% | 668 |
|
|
2018
Q1 | $440K | Buy |
4,267
+24
| +0.6% | +$2.48K | 0.01% | 734 |
|
|
2017
Q4 | $362K | Sell |
4,243
-133
| -3% | -$11.3K | 0.01% | 772 |
|
|
2017
Q3 | $371K | Buy |
4,376
+2,569
| +142% | +$218K | 0.01% | 767 |
|
|
2017
Q2 | $136K | Sell |
1,807
-41
| -2% | -$3.09K | ﹤0.01% | 1133 |
|
|
2017
Q1 | $122K | Sell |
1,848
-829
| -31% | -$54.7K | ﹤0.01% | 1159 |
|
|
2016
Q4 | $168K | Sell |
2,677
-83
| -3% | -$5.21K | ﹤0.01% | 1076 |
|
|
2016
Q3 | $174K | Buy |
2,760
+64
| +2% | +$4.04K | ﹤0.01% | 998 |
|
|
2016
Q2 | $200K | Buy |
+2,696
| New | +$200K | 0.01% | 840 |
|